Log In
BCIQ
Print this Print this
 

Silibinin IV (Legalon SIL)

  Manage Alerts
Collapse Summary General Information
Company Mylan N.V.
DescriptionHCV RNA polymerase inhibitor
Molecular Target HCV RNA
Mechanism of ActionRNA polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis
Indication DetailsTreat hepatitis C recurrence in liver transplantation
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today